Pharmafile Logo

Free Thinking – US Presidential Election: The legacy of the Affordable Care Act and the future for healthcare

October 31, 2016 | US healthcare 

Our latest Free Thinking white paper explores the legacy of the Affordable Care Act and the future for healthcare

Our latest Free Thinking white paper explores the legacy of the Affordable Care Act and the future for healthcareAs US citizens prepare to vote for a new President on Tuesday 8th November, we ask, what is the likely impact of a Republican or Democrat win on the future of the ACA, the health system and the pharma industry?

We spoke to John Leifer, author and strategic consultant to the healthcare industry, to see which way he thinks the wind is blowing. 

Download our complimentary Free Thinking white paper which looks at:

– The Affordable Care Act: in principle and practice
– Where the candidates stand
– The impact of recent pricing scandals
– The effect on pharma
– The need to demonstrate real long-term value

http://www.researchpartnership.com/news/2016/10/free-thinking-us-presidential-election-future-for-he…

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Quantitative specialist joins Research Partnership, London

Global healthcare market research consultancy Research Partnership has appointed Roy Rogers as a Quantitative Director in their UK offices in London

Webcast

Amplifying the patient voice: How to conduct patient research sensitively to uncover emotional insights

Webcast

The power of a good story: Turn your insights into effective storytelling with data visualisation

Article

How will COVID-19 affect uptake of vaccinations against other diseases?

Podcast

Living With Chronic Illness (Series one)

Webcast

China: How pharma can maximize success in this rapidly changing emerging market

Article

Inhale, Exhale: The struggle of living with Severe Asthma and Severe Eosinophilic Asthma

Infographic

Migraine market snapshot

Webcast

Monitoring the impact of COVID-19 on the market access landscape

Live webinar from Singapore

Digital #marcomms: How to evaluate and optimise marketing activities impacted by COVID-19